Daniel A. Haber

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
Mishra A, Huang SB, Dubash T, et al. (2024) Tumor cell-based liquid biopsy using high-throughput microfluidic enrichment of entire leukapheresis product. Biorxiv : the Preprint Server For Biology
Saylor PJ, Otani K, Balza R, et al. (2024) Circulating and Imaging Biomarkers of Radium-223 Response in Metastatic Castration-Resistant Prostate Cancer. Jco Precision Oncology. 8: e2300230
Takahashi M, Chong HB, Zhang S, et al. (2023) DrugMap: A quantitative pan-cancer analysis of cysteine ligandability. Biorxiv : the Preprint Server For Biology
Burr R, Leshchiner I, Costantino CL, et al. (2023) Germline mutations and developmental mosaicism underlying -mutant lung cancer. Medrxiv : the Preprint Server For Health Sciences
Guo H, Vuille JA, Wittner BS, et al. (2023) DNA hypomethylation silences anti-tumor immune genes in early prostate cancer and CTCs. Cell
Fox DB, Ebright RY, Hong X, et al. (2023) Downregulation of KEAP1 in melanoma promotes resistance to immune checkpoint blockade. Npj Precision Oncology. 7: 25
Matsuda S, Revandkar A, Dubash TD, et al. (2023) TGF-β in the microenvironment induces a physiologically occurring immune-suppressive senescent state. Cell Reports. 42: 112129
Micalizzi DS, Che D, Nicholson BT, et al. (2022) Targeting breast and pancreatic cancer metastasis using a dual-cadherin antibody. Proceedings of the National Academy of Sciences of the United States of America. 119: e2209563119
Burr R, Edd JF, Chirn B, et al. (2022) Negative-Selection Enrichment of Circulating Tumor Cells from Peripheral Blood Using the Microfluidic CTC-iChip. Methods in Molecular Biology (Clifton, N.J.). 2471: 309-321
Karabacak NM, Zheng Y, Dubash TD, et al. (2022) Differential kinase activity across prostate tumor compartments defines sensitivity to target inhibition. Cancer Research